53 related articles for article (PubMed ID: 25798447)
1. Encephalomyeloneuropathy with CRMP-5 antibodies in a patient with a primary mediastinal serinoma.
Hampton CW; Galperin D; Alvarez E; West MS
Neurol Neuroimmunol Neuroinflamm; 2015 Jun; 2(3):e82. PubMed ID: 25798447
[No Abstract] [Full Text] [Related]
2. Erratum: Encephalomyeloneuropathy with CRMP-5 antibodies in a patient with a primary mediastinal serinoma.
Neurol Neuroimmunol Neuroinflamm; 2015 Aug; 2(4):e133. PubMed ID: 26140283
[TBL] [Abstract][Full Text] [Related]
3. Tubulin and CRMP-2 complex is transported via Kinesin-1.
Kimura T; Watanabe H; Iwamatsu A; Kaibuchi K
J Neurochem; 2005 Jun; 93(6):1371-82. PubMed ID: 15935053
[TBL] [Abstract][Full Text] [Related]
4. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly.
Fukata Y; Itoh TJ; Kimura T; Ménager C; Nishimura T; Shiromizu T; Watanabe H; Inagaki N; Iwamatsu A; Hotani H; Kaibuchi K
Nat Cell Biol; 2002 Aug; 4(8):583-91. PubMed ID: 12134159
[TBL] [Abstract][Full Text] [Related]
5. GSK-3α/β-mediated phosphorylation of CRMP-2 regulates activity-dependent dendritic growth.
Tan M; Ma S; Huang Q; Hu K; Song B; Li M
J Neurochem; 2013 Jun; 125(5):685-97. PubMed ID: 23470087
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC.
Oliemuller E; Peláez R; Garasa S; Pajares MJ; Agorreta J; Pío R; Montuenga LM; Teijeira A; Llanos S; Rouzaut A
Int J Cancer; 2013 May; 132(9):1986-95. PubMed ID: 23023514
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the Akt/GSK-3β/CRMP-2 pathway in axonal injury after hypoxic-ischemic brain damage in neonatal rat.
Xiong T; Tang J; Zhao J; Chen H; Zhao F; Li J; Qu Y; Ferriero D; Mu D
Neuroscience; 2012 Aug; 216():123-32. PubMed ID: 22554777
[TBL] [Abstract][Full Text] [Related]
8. CRMP-2 directly binds to cytoplasmic dynein and interferes with its activity.
Arimura N; Hattori A; Kimura T; Nakamuta S; Funahashi Y; Hirotsune S; Furuta K; Urano T; Toyoshima YY; Kaibuchi K
J Neurochem; 2009 Oct; 111(2):380-90. PubMed ID: 19659462
[TBL] [Abstract][Full Text] [Related]
9. Collapsin response mediator protein-4 (CRMP-4) expression in posthaching development of song control nuclei in Bengalese finches.
Zhu N; Sun Y; Zeng S; Zhang X; Zuo M
Brain Res Bull; 2008 Aug; 76(6):551-8. PubMed ID: 18598844
[TBL] [Abstract][Full Text] [Related]
10. Calpain-mediated cleavage of collapsin response mediator protein(CRMP)-2 during neurite degeneration in mice.
Touma E; Kato S; Fukui K; Koike T
Eur J Neurosci; 2007 Dec; 26(12):3368-81. PubMed ID: 18052987
[TBL] [Abstract][Full Text] [Related]
11. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism.
Petratos S; Li QX; George AJ; Hou X; Kerr ML; Unabia SE; Hatzinisiriou I; Maksel D; Aguilar MI; Small DH
Brain; 2008 Jan; 131(Pt 1):90-108. PubMed ID: 18000012
[TBL] [Abstract][Full Text] [Related]
12. GSK-3 mediates the okadaic acid-induced modification of collapsin response mediator protein-2 in human SK-N-SH neuroblastoma cells.
Ni MH; Wu CC; Chan WH; Chien KY; Yu JS
J Cell Biochem; 2008 Apr; 103(6):1833-48. PubMed ID: 17902168
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones.
Arimura N; Ménager C; Kawano Y; Yoshimura T; Kawabata S; Hattori A; Fukata Y; Amano M; Goshima Y; Inagaki M; Morone N; Usukura J; Kaibuchi K
Mol Cell Biol; 2005 Nov; 25(22):9973-84. PubMed ID: 16260611
[TBL] [Abstract][Full Text] [Related]
14. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity.
Yoshimura T; Kawano Y; Arimura N; Kawabata S; Kikuchi A; Kaibuchi K
Cell; 2005 Jan; 120(1):137-49. PubMed ID: 15652488
[TBL] [Abstract][Full Text] [Related]
15. Induction of CRMP-2 by GDNF and analysis of the CRMP-2 promoter region.
Kodama Y; Murakumo Y; Ichihara M; Kawai K; Shimono Y; Takahashi M
Biochem Biophys Res Commun; 2004 Jul; 320(1):108-15. PubMed ID: 15207709
[TBL] [Abstract][Full Text] [Related]
16. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.
Yu Z; Kryzer TJ; Griesmann GE; Kim K; Benarroch EE; Lennon VA
Ann Neurol; 2001 Feb; 49(2):146-54. PubMed ID: 11220734
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of collapsin response mediator protein-2 regulates its localization and association with hippocampal cholinergic neurostimulating peptide precursor in the hippocampus.
Mizuno M; Kato D; Kanamori T; Toyoda T; Suzuki T; Ojika K; Matsukawa N
Neurosci Lett; 2013 Feb; 535():122-7. PubMed ID: 23276635
[TBL] [Abstract][Full Text] [Related]
18. Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity.
Fang W; Gao G; Zhao H; Xia Y; Guo X; Li N; Li Y; Yang Y; Chen L; Wang Q; Li L
Brain Res; 2015 Mar; 1602():9-19. PubMed ID: 25150591
[TBL] [Abstract][Full Text] [Related]
19. Crystal and solution structure, stability and post-translational modifications of collapsin response mediator protein 2.
Majava V; Löytynoja N; Chen WQ; Lubec G; Kursula P
FEBS J; 2008 Sep; 275(18):4583-96. PubMed ID: 18699782
[TBL] [Abstract][Full Text] [Related]
20. The CRMP family of proteins and their role in Sema3A signaling.
Schmidt EF; Strittmatter SM
Adv Exp Med Biol; 2007; 600():1-11. PubMed ID: 17607942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
